Chinese Biopharma Firm Zai Lab Completes $150M US Listing, Shares Jump 55%

    Categories: ExitsHealthcareVenture Capital

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related News

This website uses cookies.